0
0
Home » Pharmaceuticals

Cystic Fibrosis – Global Clinical Trials Review, H2, 2021

This report provides top-line data relating to the clinical trials on cystic fibrosis. This report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. Moreover, the report provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).

The cystic fibrosis clinical trial report consists of 1164 trials conducted by companies in Phase IV, Phase III, Phase II, and Phase I. Out of 823 completed trials, over 400 trials have achieved end points. The number of cystic fibrosis clinical trials conducted globally has decreased by 30% for the period 2016-2020. The average number of patients enrolled was highest in the year 2020. More than 50% of the trials have been sponsored by companies and over 40% by institutions.

What are the top regions and countries in the cystic fibrosis clinical trials market?

In total there were 1,164 clinical trials conducted on cystic fibrosis. Out of them, more than 35% were conducted in Europe and North America. It was followed by Asia-Pacific with more than 10%, the Middle East and Africa at about 5% each, and the lowest was South and Central America. The UK had the highest number of cystic fibrosis clinical trials among the European countries, accounting for nearly 30% of the clinical trials in the region. The US had the highest number of cystic fibrosis clinical trials in North America and Australia had the highest number of cystic fibrosis clinical trials in the Asia-Pacific region. Israel had the highest number of cystic fibrosis clinical trials in the Middle East and Africa and Argentina had the highest number of cystic fibrosis clinical trials in South and Central America.

In the country-wise analysis, the US had the highest number of cystic fibrosis clinical trials as well as the highest number of trials in progress. The US is followed by the UK and Germany in the highest number of trials. Spain had the highest average patient enrollment in cystic fibrosis clinical trials. Other top countries include Canada, Australia, Belgium, France, Italy, and the Netherlands.

Cystic fibrosis clinical trials market in G7 countries

Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, there were 1,107 clinical trials conducted as of December 2021. Of these, the US had the highest number of clinical trials. France has the highest proportion of cystic fibrosis to respiratory clinical trials as of December 2021.

Cystic fibrosis clinical trials market in E7 countries:

As of December 2021, among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, there were a total of 61 clinical trials being conducted. Of these, Russia had the highest number of clinical trials as well as the highest proportion of cystic fibrosis to respiratory clinical trials.

Cystic fibrosis clinical trials market, by region

Cystic fibrosis clinical trials market, by region

For more regional insights, download a free report sample

What are the phases in the cystic fibrosis clinical trials market?

As of December 2021, there were 414 clinical trials in Phase II, of which over 40 clinical trials were in progress for the time period of 1995-2021. Phase II had the maximum number of clinical trials in progress accounting for more than 30% of the trials.

Which are the key sponsors in the cystic fibrosis clinical trials market?

The key sponsors in the cystic fibrosis clinical trials market are Vertex Pharmaceuticals Inc, Cystic Fibrosis Foundation, Novartis AG, Gilead Sciences Inc, C. H. Boehringer Sohn AG & Co KG, Galapagos NV, F. Hoffmann-La Roche Ltd, AbbVie Inc, Merck & Co Inc, and Yumanity Therapeutics Inc. Among them, Vertex Pharmaceuticals Inc has conducted the highest number of cystic fibrosis clinical trials.

Cystic fibrosis clinical trials market, by key sponsorsCystic fibrosis clinical trials market, by key sponsors

To know more about key sponsors, download a free report sample

Market report scope

Key regions Europe, Northern America, Asia-Pacific, Middle East and Africa, and South and Central America
Key countries The US, The UK, Germany, Spain, Canada, Australia, Belgium, France, Italy, and the Netherlands
Key sponsors Vertex Pharmaceuticals Inc, Cystic Fibrosis Foundation, Novartis AG, Gilead Sciences Inc, C. H. Boehringer Sohn AG & Co KG, Galapagos NV, F. Hoffmann-La Roche Ltd, AbbVie Inc, Merck & Co Inc, and Yumanity Therapeutics Inc

The report provides an in-depth analysis of:

  • Top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status.
  • Top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
  • All the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for unaccomplishment.
  • Enrollment trends for the past five years.
  • Latest news for the past three months.

Reasons to Buy

  • Assists in formulating key business strategies with regard to investment.
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities.
  • Supports understanding of trials count and enrollment trends by country in the global therapeutics market.
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
  • Facilitates clinical trial assessment of the indication on a global, regional, and country-level.

Key Players

Vertex Pharmaceuticals Inc

Cystic Fibrosis Foundation

Novartis AG

Gilead Sciences Inc

C. H. Boehringer Sohn AG & Co KG

Galapagos NV

F. Hoffmann-La Roche Ltd

AbbVie Inc

Merck & Co Inc

Yumanity Therapeutics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Cystic Fibrosis Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source

List of Tables

List of Tables

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2021*

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2021*

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020

Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*

Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2021*

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*

Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*

Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2021*

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*

Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*

Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020

Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*

Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

GlobalData Methodology

Frequently Asked Questions

The key regions in the cystic fibrosis clinical trials market are Europe, North America, Asia-Pacific, the Middle East and Africa, and South and Central America.

The key countries in the cystic fibrosis clinical trials market are the US, the UK, Germany, Spain, Canada, Australia, Belgium, France, Italy, and the Netherlands.

The key sponsors in the cystic fibrosis clinical trials market are Vertex Pharmaceuticals Inc, Cystic Fibrosis Foundation, Novartis AG, Gilead Sciences Inc, C. H. Boehringer Sohn AG & Co KG, Galapagos NV, F. Hoffmann-La Roche Ltd, AbbVie Inc, Merck & Co Inc, and Yumanity Therapeutics Inc

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports